| Date | Title | Presentation | Webcast | | December 7, 2010 | Presentation at the NASDAQ OMX 25th Investor Program | |  | | November 11, 2010 | Presentation at the Credit Suisse 2010 Healthcare Conference |  |  | | November 4, 2010 | Teva Respiratory Opportunity Business Update Meeting |  |  | | November 3, 2010 | Development of Biosimilars in the U.S. - Teva's Position on Key Issues |  | | | September 17, 2010 | Presentation at the BofA Merrill Lynch Global Healthcare Conference |  | | | July 27, 2010 | 2nd Quarter 2010 Investor Presentation (Israel) |  | | | June 2, 2010 | Presentation at UBS Global Specialty Pharmaceuticals Conference |  | | | May 13, 2010 | Presentation at the Bank of America Merrill Lynch Annual Health Care Conference |  | | | May 5, 2010 | Presentation at the Deutsche Bank 35th Annual Health Care Conference |  | | | March 8, 2010 | Presentation on the Acquisition of ratiopharm |  | | | March 8, 2010 | Presentation at the Cowen and Company 30th Annual Healthcare Conference |  | | | February 24, 2010 | Presentation at the NASDAQ OMX and Oppenheimer & Co. Inc. 14th Annual Israeli Equities Conference |  | | | February 16, 2010 | Presentation to Israeli Capital Market Q4-09 and Full Year 2009 Results |  | | | January 11, 2010 | Presentation At The 28th Annual J.P. Morgan Healthcare Conference |  | | | January 7, 2010 | Teva Strategy Review 2010-2015 |  | |
|